MGMT 8114 Strategic Issues in the Biopharmaceutical Industry (Fall: 3 )
This course evaluates strategic challenges and opportunities faced by life science companies. We will review: US health care system versus global alternatives, Global burden of disease and treatment paradigm, Industry benchmarks for R&D, Business Development, and Commercialization. We will consider specific strategic issues facing the industry, e.g. emerging markets opportunity, R&D productivity challenges, Portfolio management approaches, Increasing role of academia and bio-tech in discovery. Guest lecturers working within the industry will speak to strategic issues. Students will be asked to complete two typical consulting projects focusing on a particular disease state and/or strategic issue.
Instructor(s): Frank Deane
Last Updated: 21-Sep-15